For: | Broquetas T, Carrión JA. Past, present, and future of long-term treatment for hepatitis B virus. World J Gastroenterol 2023; 29(25): 3964-3983 [PMID: 37476586 DOI: 10.3748/wjg.v29.i25.3964] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v29/i25/3964.htm |
Number | Citing Articles |
1 |
Xiaohui Fang, Yuhang Yin, Haonan Zhao, Cai’e Wang, Hui Li, Yiyang Shang, Jiayu Li, Yue Gao, Nahum Méndez-Sánchez, Xingshun Qi. Effect of fatty liver disease on liver function and fibrosis in patients with chronic hepatitis B: a cross-sectional study. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1481051
|
2 |
Valeria Reynolds-Cortez, Juan-José Criado-Álvarez, Vicente Martinez-Vizcaino, Carlos Pascual-Morena, Ana Salinas-Vilca, Irene Sequí-Domínguez. The Effectiveness and Sero-Immunity of Hepatitis B Vaccination in People Who Use Drugs: A Systematic Review and Meta-Analysis. Vaccines 2024; 12(9): 1026 doi: 10.3390/vaccines12091026
|
3 |
Jianpeng Wang, Xinyi Wang, Enba Zhuo, Bangjie Chen, Shixin Chan. Gut‑liver axis in liver disease: From basic science to clinical treatment (Review). Molecular Medicine Reports 2024; 31(1) doi: 10.3892/mmr.2024.13375
|
4 |
Pojsakorn Danpanichkul, Kanokphong Suparan, Nathorn Chaiyakunapruk, Thanida Auttapracha, Siwanart Kongarin, Phuuwadith Wattanachayakul, Vijay Ramadoss, Thanathip Suenghataiphorn, Banthoon Sukphutanan, Yanfang Pang, Rashid N. Lui, Ju Dong Yang, Mazen Noureddin, Luis Antonio Díaz, Suthat Liangpunsakul, Juan Pablo Arab, Karn Wijarnpreecha. Alcohol-related liver and extrahepatic malignancies: burden of disease and socioeconomic disparities in 2019. European Journal of Gastroenterology & Hepatology 2024; doi: 10.1097/MEG.0000000000002882
|
5 |
Zi-Hong Bao, Zhi-Kun Dai, Hao-Xian Tang. Antiviral treatment standards for hepatitis B: An urgent need for expansion. World Journal of Gastroenterology 2024; 30(4): 418-420 doi: 10.3748/wjg.v30.i4.418
Abstract(360) |
Core Tip(368) |
Full Article(HTML)(964)
|
Full Article with Cover (PDF)-770K(61)
|
Full Article (Word)-104K(14)
|
Audio-627K(8)
|
Peer-Review Report-197K(43)
|
Answering Reviewers-80K(50)
|
Full Article (PDF)-336K(93)
|
Full Article (XML)-30K(37)
|
Times Cited (1)
|
Total Visits (2767)
|
Open
|
6 |
Yiqi Xiong, Wenying Qiao, Qi Wang, Kang Li, Ronghua Jin, Yonghong Zhang. Construction and validation of a machine learning-based nomogram to predict the prognosis of HBV associated hepatocellular carcinoma patients with high levels of hepatitis B surface antigen in primary local treatment: a multicenter study. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1357496
|
7 |
Samuel W. Gillespie, Athreya S. Reddy, Dana M. Burris, S. Hasan Naqvi, Siddappa N. Byrareddy, Christian L. Lorson, Kamal Singh. Islatravir: evaluation of clinical development for HIV and HBV. Expert Opinion on Investigational Drugs 2024; 33(2): 85 doi: 10.1080/13543784.2024.2305130
|
8 |
Fabiola Di Dato, Raffaele Iorio. Expanding indications for chronic hepatitis B treatment: Is it really desirable to treat everyone?. World Journal of Gastroenterology 2024; 30(17): 2294-2297 doi: 10.3748/wjg.v30.i17.2294
|